Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Medtronic acquired Stimgenics in January 2020 to expand its portfolio in Differential Target Multiplexed Spinal Cord ...

Deep Brain Stimulator MarketThe global deep brain stimulator market, valued at USD 1308.0 Million in 2024, is projected to grow steadily, reaching USD  2772.1 billion by 2034. With an anticipated CAGR ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

using spinal cord transcutaneous stimulation (scTS). This promising approach to enhance cardiovascular regulation addresses the challenges of unstable blood pressure and the accompanying ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Medtronic devices) with modern SCS systems. The researchers concluded, “Although SCS and DRG stimulation are well-established and safe treatment for chronic pain, the long-term explantation risk ...

Medtronic makes the device that Kim received ... It's connected to the battery, and the battery delivers an electrical signal that is delivered to the spinal cord. Hence the term spinal cord ...

At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows. Rates of treatment response and depression remission were three times ...

TUESDAY, Oct. 22, 2024 (HealthDay News) -- At-home brain stimulation therapy can safely and effectively treat severe to moderate depression, a new clinical trial shows. Rates of treatment response ...